Medical anti-adhesion material with controllable degradation and preparation method thereof

An anti-adhesion film and film material technology, applied in the field of biomedical materials, can solve the problems of inability to seal and isolate nerve roots, poor long-term effect, and unfavorable prevention of adhesion, and achieve good hemostatic and anti-inflammatory effects and cost. Low, good adhesion effect

Inactive Publication Date: 2012-03-21
KUNMING UNIV OF SCI & TECH
View PDF4 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, some anti-adhesion materials such as sodium hyaluronate gel, chitin gel and other fluid materials degrade relatively quickly, and are easy to lose with the change of body position. The short-term effect is better in the process of preventing adhesion, but the long-term effect is not good. Good; while some membrane materials, such as carboxymethyl chitosan membrane, will produce inflammatory response to the matrix (Zhou Gui et al., Chinese Tissue Engineering Research and Clinical Rehabilitation, 2009, 13 (18): 1411-1418), and the degradation is relatively slow Fast; polylactic acid is also a commonly used anti-adhesion material, but the degradation rate of polylactic acid film is slow, generally 3 to 6 months to fully absorb, and poor adhesion to the dura mater, easy to produce space between the dura mater and hematoma Existence is not conducive to the prevention of adhesion, especially the sealing and isolation of nerve roots (Sun Shaohua et al., Chinese journal of bone and joint injury.2006,21(7):590-591); but the material of the present invention is A kind of degradation is controllable, the degradation product is non-toxic, has good water absorption, can stop bleeding and reduce the formation of hematoma, good elasticity can be well attached to the adhesion part, and has good biological properties compatibility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] Embodiment 1: The preparation method of the medical anti-adhesion film material with controllable degradation is:

[0027] (1) Prepare mixed dry powder: mix 7.999wt% sodium hyaluronate of the anti-adhesion film material with 85wt% konjac fine powder of the anti-adhesion film material (konjac fine powder is untreated konjac glucomannan containing 70wt%) any modified natural konjac powder), and stir well;

[0028] (2) Prepare lactic acid solution: dissolve 7wt% lactic acid of the anti-adhesion film material in deionized water at a volume ratio of 100:1 between deionized water and lactic acid, and stir evenly;

[0029] (3) Prepare mixed glue: mix the mixed dry powder prepared in step (1) and the lactic acid solution prepared in step (1) at a solid-to-liquid ratio of 20:1g / L, stir evenly, seal and then microwave for 2 minutes. After filtering through a 200-mesh sieve to remove impurities, place it under a negative pressure of 450 mm Hg for 12 hours for degassing;

[0030]...

Embodiment 2

[0033] Embodiment 2: The preparation method of this degradable controllable medical anti-adhesion film material is:

[0034] (1) Preparation of mixed dry powder: mix 0.1wt% zinc hyaluronate of the anti-adhesion film material with 54.997wt% konjac fine powder of the anti-adhesion film material (konjac fine powder is untreated konjac glucomannan containing 80wt%) natural konjac powder with any modification), and stir well;

[0035] (2) Prepare lactic acid solution: dissolve 44.9wt% lactic acid of the anti-adhesion film material in deionized water at a volume ratio of 200:1 between deionized water and lactic acid, and stir evenly;

[0036] (3) Prepare mixed glue: mix the mixed dry powder prepared in step (1) and the lactic acid solution prepared in step (1) at a solid-to-liquid ratio of 25:2g / L, stir evenly, seal and then microwave for 8 minutes. After filtering through a 200-mesh sieve to remove impurities, place it under a negative pressure of 400 mm Hg for 12 hours for degass...

Embodiment 3

[0040] Embodiment 3: The preparation method of this degradable controllable medical anti-adhesion film material is:

[0041] (1) Prepare mixed dry powder: mix 8wt% copper hyaluronate of the anti-adhesion film material with 85wt% konjac fine powder of the anti-adhesion film material (konjac fine powder is konjac glucomannan containing 90wt% without any modified natural konjac flour), and stir evenly;

[0042] (2) Prepare lactic acid solution: dissolve 15wt% lactic acid of the anti-adhesion film material in deionized water at a ratio of 400:1 by volume of deionized water to lactic acid, and stir evenly;

[0043] (3) Prepare mixed glue: mix the mixed dry powder prepared in step (1) and the lactic acid solution prepared in step (1) at a solid-to-liquid ratio of 35:4g / L, stir evenly, seal and then microwave for 10 minutes. After filtering through a 200-mesh sieve to remove impurities, place it under a negative pressure of 500 mm Hg for 12 hours for degassing;

[0044] (4) Tape ca...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medical anti-adhesion membrane material with controllable degradation and a preparation method thereof, belonging to the field of biomedical materials. According to the invention, the membrane material is prepared by blending sodium hyaluronate and konjac klucomannan, using lactic acid as a property-modifying additive and using a mixed solution of ammonia water and anhydrous ethanol as a cross-linking agent; sodium hyaluronate is a good anti-adhesion material, but individually used sodium hyaluronate has a fast degradation speed and can not fulfill a good anti-adhesion effect; konjac klucomannan can control the degree of cross-linking, thereby realizing the goal of controllable degradation, and blending of sodium hyaluronate and konjac klucomannan enables sodium hyaluronate to be released slowly, thereby allowing the membrane material to meet demands for anti-adhesion action at different parts. The membrane material has the advantages of nontoxic degradation products, good biocompatibility, hygroscopicity and tensile properties, and the like, and can be used for intervertebral adhesion, intestinal adhesion, skin adhesion, intrauterine adhesion, etc.

Description

technical field [0001] The invention relates to a medical anti-adhesion film material with controllable degradation and a preparation method thereof, which can be used for lamina anti-adhesion, corneal adhesion, intestinal adhesion, uterine cavity adhesion, etc., and belongs to the field of biomedical materials. Background technique [0002] Postoperative adhesions are a common complication after surgery such as laminectomy, fibrosis and scarring around the dura mater [0003] The formation of scars can cause adhesion between the dura mater and the nerve root, thereby causing pressure on the dural sac, which is one of the main reasons for the failure syndrome of lower lumbar spine surgery; intestinal adhesion after laparotomy is also a major problem in clinical work. Due to postoperative adhesions, the incidence of intestinal obstruction is high, and repeated attacks affect the quality of life; intrauterine adhesions are a common gynecological disease, mainly caused by endom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61L15/28A61L15/42A61L31/04A61L31/14C08J7/12C08J3/24
Inventor 陈庆华陈佳王静黄明华
Owner KUNMING UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products